China Regenerative Medicine International Limited

SEHK:8158 Rapport sur les actions

Capitalisation boursière : HK$130.8m

China Regenerative Medicine International Gestion

Gestion contrôle des critères 3/4

Le PDG China Regenerative Medicine International est Chuang Wang, nommé en Jul2020, a un mandat de 4.33 ans. La rémunération annuelle totale est HK$ 1.46M, composée du salaire de 85.3% et des bonus 14.7%, y compris les actions et options de la société. détient directement 24.28% des actions de la société, d'une valeur de HK$ 31.77M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.3 ans et 3.9 ans.

Informations clés

Chuang Wang

Directeur général

HK$1.5m

Rémunération totale

Pourcentage du salaire du PDG85.3%
Durée du mandat du directeur général4.3yrs
Propriété du PDG24.3%
Durée moyenne d'occupation des postes de direction4.3yrs
Durée moyenne du mandat des membres du conseil d'administration3.9yrs

Mises à jour récentes de la gestion

Recent updates

Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

Mar 05
Little Excitement Around China Regenerative Medicine International Limited's (HKG:8158) Revenues As Shares Take 32% Pounding

China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

Jan 04
China Regenerative Medicine International Limited's (HKG:8158) Price Is Right But Growth Is Lacking After Shares Rocket 57%

These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

Sep 21
These 4 Measures Indicate That China Regenerative Medicine International (HKG:8158) Is Using Debt Extensively

China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Jun 11
China Regenerative Medicine International Limited (HKG:8158) May Have Run Too Fast Too Soon With Recent 31% Price Plummet

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

May 22
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Apr 13
Is China Regenerative Medicine International (HKG:8158) A Risky Investment?

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Sep 22
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

Mar 16
Introducing China Regenerative Medicine International (HKG:8158), The Stock That Zoomed 142% In The Last Year

What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Feb 08
What Is The Ownership Structure Like For China Regenerative Medicine International Limited (HKG:8158)?

Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Dec 15
Trade Alert: The CEO & Executive Chairman Of China Regenerative Medicine International Limited (HKG:8158), Chuang Wang, Has Just Spent HK$55m Buying 428% More Shares

Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Nov 25
Don't Ignore The Fact That This Insider Just Sold Some Shares In China Regenerative Medicine International Limited (HKG:8158)

Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Nov 24
Does China Regenerative Medicine International (HKG:8158) Have A Healthy Balance Sheet?

Analyse de la rémunération des PDG

Comment la rémunération de Chuang Wang a-t-elle évolué par rapport aux bénéfices de China Regenerative Medicine International?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-HK$104m

Mar 31 2024n/an/a

-HK$101m

Dec 31 2023HK$1mHK$1m

-HK$108m

Sep 30 2023n/an/a

HK$677k

Jun 30 2023n/an/a

HK$15m

Mar 31 2023n/an/a

HK$5m

Dec 31 2022HK$1mn/a

HK$5m

Sep 30 2022n/an/a

HK$31m

Jun 30 2022n/an/a

HK$26m

Mar 31 2022n/an/a

HK$49m

Dec 31 2021HK$1mn/a

HK$52m

Sep 30 2021n/an/a

-HK$95m

Jun 30 2021n/an/a

-HK$82m

Mar 31 2021n/an/a

-HK$105m

Dec 31 2020HK$1mn/a

-HK$120m

Sep 30 2020n/an/a

-HK$201m

Jun 30 2020n/an/a

-HK$237m

Mar 31 2020n/an/a

-HK$239m

Dec 31 2019HK$245kHK$245k

-HK$264m

Rémunération vs marché: La rémunération totale de Chuang ($USD 188.03K ) est dans la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 233.89K ).

Rémunération et revenus: La rémunération de Chuang a augmenté alors que l'entreprise n'est pas rentable.


PDG

Chuang Wang (45 yo)

4.3yrs

Titularisation

HK$1,461,000

Compensation

Mr. Chuang Wang has been Executive Chairman at China Regenerative Medicine International Limited since October 18, 2019 and serves as its Chief Executive Officer since July 9, 2020 and also serves as its C...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Chuang Wang
CEO, Executive Chairman & Compliance Officer4.3yrsHK$1.46m24.28%
HK$ 31.8m
Po Tin Wong
CFO & Company Secretary2.2yrspas de donnéespas de données
Jinnan Zhang
Chief Technology Officer6.2yrspas de donnéespas de données

4.3yrs

Durée moyenne de l'emploi

45yo

Âge moyen

Gestion expérimentée: L'équipe de direction de 8158 est considérée comme expérimentée (ancienneté moyenne 4.3 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Chuang Wang
CEO, Executive Chairman & Compliance Officer5.1yrsHK$1.46m24.28%
HK$ 31.8m
Man Fai Leung
Independent Non-Executive Director2.9yrsHK$120.00kpas de données
Chunyu Huo
Independent Non-Executive Director4.8yrsHK$120.00kpas de données
Ming Liu
Independent Non-Executive Director2.9yrsHK$120.00kpas de données

3.9yrs

Durée moyenne de l'emploi

58yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 8158 sont considérés comme expérimentés (ancienneté moyenne 3.9 ans).